1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934
DATE OF REPORT - OCTOBER 25, 1999
AMERICAN VANGUARD CORPORATION
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-6354 95-2588080
- ------------------------ --------------------- ------------------
(State of incorporation) (Commission File No.) (IRS Employer No.)
4695 MACARTHUR COURT, NEWPORT BEACH, CALIFORNIA 92660
- ----------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
(949) 260-1200
- --------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
2
ITEM 5. OTHER EVENTS.
On October 18, 1999, American Vanguard Corporation issued the press
release attached hereto as Exhibit 99.1. The release announced that Amvac
Chemical Corporation, a wholly-owned subsidiary of American Vanguard
Corporation, resolved certain litigation regarding its exclusive ownership of
labels and registration with the Environmental Protection Agency for naphthalene
acetic acid all as more particularly described in Exhibit 99.1.
ITEM 7. EXHIBITS.
99.1 Press release issued October 18, 1999.
2
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN VANGUARD CORPORATION
Date: October 25, 1999 By: /s / J. A. Barry
----------------------------
J. A. Barry
Senior Vice President
Chief Financial Officer
3
4
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------- -----------
99.1 Press Release issued October 18, 1999